Differential Expression Profiling of MicroRNAs in Para-carcinoma, Carcinoma and Relapse Human Pancreatic Cancer

Overview

Journal Clin Transl Oncol

Specialty Oncology

Date 2014 Nov 13

PMID 25387567

Citations 5

Authors

X-L Lai

Y-H Huang

Y-S Li

G-N Li

L-P Wang

R Sun

Y-S Ma

S-Y Feng

Z-Y Chang

X-H Wang

D Fu

X Han

X-L Cong

W-P Li

Affiliations

Soon will be listed here.

Abstract

Purpose: To explore the altered different expression of miRNAs and the mechanisms underlying the relapse and metastasis of pancreatic cancer.

Materials And Methods: The most differentially expressed miRNAs were analyzed by gene ontology (GO) term analysis, Kyoto encyclopedia of genes and genomes (KEGG) pathway analysis and protein interaction analysis. The potentially regulated target genes of the most differentially expressed miRNAs were also analyzed further by GO term analysis and KEGG pathway analysis, and quantitated by qRT-PCR.

Results: In total, we found 12 miRNAs displayed at least a 30-fold increase or decrease in expression of carcinoma and relapse vs. para-carcinoma human pancreatic cancer (C/R vs. P). In addition, our study found that pancreatic cancer was related to pathways in cancer, including Jak-STAT signaling pathway, MAPK signaling pathway and PPAR signaling pathway.

Conclusions: The differential expressed miRNAs and their predicted target genes that involved in Jak-STAT signaling pathway, MAPK signaling pathway and PPAR signaling pathway indicating their potential roles in pancreatic carcinogenesis and progress.

Citing Articles

CENPN contributes to pancreatic carcinoma progression through the MDM2-mediated p53 signaling pathway.

Xu M, Tang J, Sun Q, Meng J, Chen G, Chang Y Arch Med Sci. 2024; 20(5):1655-1671.

PMID: 39649279 PMC: 11623148. DOI: 10.5114/aoms/171956.

Differential expression of microRNAs in xenografted Lewis lung carcinomas subjected to intermittent hypoxia: a next-generation sequence analysis.

Zhang X, Lin X, Wu X, Zeng Y, Chen X, Luo X Transl Cancer Res. 2022; 9(7):4354-4365.

PMID: 35117801 PMC: 8798178. DOI: 10.21037/tcr-19-2913.

Hypoxia: a barricade to conquer the pancreatic cancer.

Tan Z, Xu J, Zhang B, Shi S, Yu X, Liang C Cell Mol Life Sci. 2020; 77(16):3077-3083.

PMID: 31907561 PMC: 11104901. DOI: 10.1007/s00018-019-03444-3.

MiR-142 modulates human pancreatic cancer proliferation and invasion by targeting hypoxia-inducible factor 1 (HIF-1α) in the tumor microenvironments.

Lu Y, Ji N, Wei W, Sun W, Gong X, Wang X Biol Open. 2017; 6(2):252-259.

PMID: 28069592 PMC: 5312097. DOI: 10.1242/bio.021774.

MicroRNA-127 is aberrantly downregulated and acted as a functional tumor suppressor in human pancreatic cancer.

Yu Y, Liu L, Ma R, Gong H, Xu P, Wang C Tumour Biol. 2016; 37(10):14249-14257.

PMID: 27571739 DOI: 10.1007/s13277-016-5270-0.

References

Jin C, Rajabi H, Kufe D . miR-1226 targets expression of the mucin 1 oncoprotein and induces cell death. Int J Oncol. 2010; 37(1):61-9. PMC: 3027208. DOI: 10.3892/ijo_00000653. View

Agell L, Hernandez S, Nonell L, Lorenzo M, Puigdecanet E, De Muga S . A 12-gene expression signature is associated with aggressive histological in prostate cancer: SEC14L1 and TCEB1 genes are potential markers of progression. Am J Pathol. 2012; 181(5):1585-94. DOI: 10.1016/j.ajpath.2012.08.005. View

Chen X, Qiu J, Yang D, Lu J, Yan C, Zha X . MDM2 promotes invasion and metastasis in invasive ductal breast carcinoma by inducing matrix metalloproteinase-9. PLoS One. 2013; 8(11):e78794. PMC: 3827260. DOI: 10.1371/journal.pone.0078794. View

Wang X, Zhu Y, Ma Y, Wang J, Zhang F, Xia Q . The role of cancer stem cells in cancer metastasis: new perspective and progress. Cancer Epidemiol. 2012; 37(1):60-3. DOI: 10.1016/j.canep.2012.07.007. View

Ali S, Saleh H, Sethi S, Sarkar F, Philip P . MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer. Br J Cancer. 2012; 107(8):1354-60. PMC: 3494446. DOI: 10.1038/bjc.2012.383. View

Chang Z, Sun R, Ma Y, Fu D, Lai X, Li Y . Differential gene expression of the key signalling pathway in para-carcinoma, carcinoma and relapse human pancreatic cancer. Cell Biochem Funct. 2013; 32(3):258-67. DOI: 10.1002/cbf.3009. View

Karami S, Andreotti G, Koutros S, Barry K, Moore L, Han S . Pesticide exposure and inherited variants in vitamin d pathway genes in relation to prostate cancer. Cancer Epidemiol Biomarkers Prev. 2013; 22(9):1557-66. PMC: 3773544. DOI: 10.1158/1055-9965.EPI-12-1454. View

He H, Han Z, Dai Q, Ling X, Fu X, Lin Z . Global analysis of the differentially expressed miRNAs of prostate cancer in Chinese patients. BMC Genomics. 2013; 14:757. PMC: 4008360. DOI: 10.1186/1471-2164-14-757. View

Sarkar S, Dubaybo H, Ali S, Goncalves P, Kollepara S, Sethi S . Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA. Am J Cancer Res. 2013; 3(5):465-77. PMC: 3816966. View

10.

Nishikawa R, Goto Y, Kojima S, Enokida H, Chiyomaru T, Kinoshita T . Tumor-suppressive microRNA-29s inhibit cancer cell migration and invasion via targeting LAMC1 in prostate cancer. Int J Oncol. 2014; 45(1):401-10. DOI: 10.3892/ijo.2014.2437. View

11.

Djos A, Martinsson T, Kogner P, Caren H . The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma. Mol Cancer. 2012; 11:40. PMC: 3493266. DOI: 10.1186/1476-4598-11-40. View

12.

Aavikko M, Li S, Saarinen S, Alhopuro P, Kaasinen E, Morgunova E . Loss of SUFU function in familial multiple meningioma. Am J Hum Genet. 2012; 91(3):520-6. PMC: 3511996. DOI: 10.1016/j.ajhg.2012.07.015. View

13.

Siegel R, Naishadham D, Jemal A . Cancer statistics, 2012. CA Cancer J Clin. 2012; 62(1):10-29. DOI: 10.3322/caac.20138. View

14.

Fang Y, Fu D, Shen X . The potential role of ubiquitin c-terminal hydrolases in oncogenesis. Biochim Biophys Acta. 2010; 1806(1):1-6. DOI: 10.1016/j.bbcan.2010.03.001. View

15.

Yamasaki T, Seki N, Yoshino H, Itesako T, Yamada Y, Tatarano S . Tumor-suppressive microRNA-1291 directly regulates glucose transporter 1 in renal cell carcinoma. Cancer Sci. 2013; 104(11):1411-9. PMC: 7654250. DOI: 10.1111/cas.12240. View

16.

Fang C, Zhao Y, Guo B . MiR-199b-5p targets HER2 in breast cancer cells. J Cell Biochem. 2013; 114(7):1457-63. DOI: 10.1002/jcb.24487. View

17.

Zhang J, Liu Y, Liu Z, Wang X, Yin D, Zheng L . Differential expression profiling and functional analysis of microRNAs through stage I-III papillary thyroid carcinoma. Int J Med Sci. 2013; 10(5):585-92. PMC: 3607244. DOI: 10.7150/ijms.5794. View

18.

Szczepanek-Parulska E, Szaflarski W, Piatek K, Budny B, Jaszczynska-Nowinka K, Biczysko M . Alternative 3' acceptor site in the exon 2 of human PAX8 gene resulting in the expression of unknown mRNA variant found in thyroid hemiagenesis and some types of cancers. Acta Biochim Pol. 2013; 60(4):573-8. View

19.

Zhang P, Wang X, Zhao W, Qi B, Yang Q, Wan H . DNA methylation-mediated repression of miR-941 enhances lysine (K)-specific demethylase 6B expression in hepatoma cells. J Biol Chem. 2014; 289(35):24724-35. PMC: 4148894. DOI: 10.1074/jbc.M114.567818. View

20.

Lujambio A, Lowe S . The microcosmos of cancer. Nature. 2012; 482(7385):347-55. PMC: 3509753. DOI: 10.1038/nature10888. View